Neil Drake

Neil Drake is a declared insider of ReShape Lifesciences Inc., with filings sourced from SEC (Form 4). Between 30 April 2017 and 23 August 2018, the trades on record add up to 10 filings.

The open-market record is one-sided, with 1 purchase worth €16k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants and 4 option exercises. In 2018 alone, the filings show 1 purchase and no sales.

The record was last updated on 27 August 2018 with a share grant (€22k) in ReShape Lifesciences Inc. The most recent open-market purchase was published on 19 March 2018, 3,157 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.